Fifth Third Bancorp’s Heron Therapeutics HRTX Stock Holding History

Fifth Third Bancorp’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.11K	Hold	4,934	–	–	﹤0.01%	4080
2026 Q1	$3.95K	Buy	+4,934	New	+$5.72K	﹤0.01%	3917
2022 Q1	–	Sell	-3,000	Closed	-$27K	–	2718
2021 Q4	$27K	Hold	3,000	–	–	﹤0.01%	1746
2021 Q3	$32K	Hold	3,000	–	–	﹤0.01%	1611
2021 Q2	$47K	Buy	+3,000	New	+$47.7K	﹤0.01%	1477
2020 Q3	–	Sell	-2,000	Closed	-$29K	–	2316
2020 Q2	$29K	Sell	2,000 -92	-4%	-$1.51K	﹤0.01%	1458
2020 Q1	$25K	Hold	2,092	–	–	﹤0.01%	1466
2019 Q4	$49K	Hold	2,092	–	–	﹤0.01%	1407
2019 Q3	$39K	Buy	2,092 +92	+5%	+$1.69K	﹤0.01%	1430
2019 Q2	$37K	Buy	2,000 +1,500	+300%	+$30K	﹤0.01%	1454
2019 Q1	$12K	Hold	500	–	–	﹤0.01%	1734
2018 Q4	$13K	Hold	500	–	–	﹤0.01%	1708
2018 Q3	$16K	Hold	500	–	–	﹤0.01%	1703
2018 Q2	$19K	Hold	500	–	–	﹤0.01%	1680
2018 Q1	$14K	Hold	500	–	–	﹤0.01%	1787
2017 Q4	$9K	Hold	500	–	–	﹤0.01%	1856
2017 Q3	$8K	Hold	500	–	–	﹤0.01%	1832
2017 Q2	$7K	Sell	500 -2,450	-83%	-$35.5K	﹤0.01%	1812
2017 Q1	$44K	Sell	2,950 -105	-3%	-$1.45K	﹤0.01%	1343
2016 Q4	$40K	Sell	3,055 -1,974	-39%	-$31K	﹤0.01%	1403
2016 Q3	$87K	Buy	5,029 +4,529	+906%	+$84K	﹤0.01%	1150
2016 Q2	$9K	Hold	500	–	–	﹤0.01%	1832
2016 Q1	$9K	Hold	500	–	–	﹤0.01%	1887
2015 Q4	$13K	Hold	500	–	–	﹤0.01%	1846
2015 Q3	$12K	Hold	500	–	–	﹤0.01%	1960
2015 Q2	$16K	Hold	500	–	–	﹤0.01%	1886
2015 Q1	$7K	Buy	+500	New	+$5.64K	﹤0.01%	2129

Other funds holding HRTX

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Fifth Third Bancorp's HRTX Position: Q2 2026 in Review

Fifth Third Bancorp held its Heron Therapeutics (HRTX) position steady in Q2 2026 at 4,934 shares worth $2.11K. The position accounts for ﹤0.01% of the portfolio, ranked #4080.

Fifth Third Bancorp first reported a position in HRTX in Q1 2015 and has held it in 27 quarters since. The position peaked at $87K in Q3 2016. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

Fifth Third Bancorp held 4,934 shares of Heron Therapeutics worth $2.11K as of Q2 2026.
Fifth Third Bancorp left its Heron Therapeutics share count unchanged in Q2 2026.
Heron Therapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4080 holding.
Fifth Third Bancorp first reported a position in Heron Therapeutics in Q1 2015 and has held it in 27 quarters since.
Fifth Third Bancorp's Heron Therapeutics position peaked at $87K in Q3 2016.
163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.